𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors

✍ Scribed by Tina W. F. Yen; Linda K. Czypinski; Rodney A. Sparapani; Changbin Guo; Purushottam W. Laud; Liliana E. Pezzin; Ann B. Nattinger

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
162 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Enzyme-linked immunosorbent assay of ps2
Enzyme-linked immunosorbent assay of ps2 in breast cancers, benign tumors, and normal breast tissues correlation with prognosis and adjuvant hormone therapy
✍ J. Predine Mpharm; F. Spyratos Mpharm; J. F. Prud'homme; C. Andrieu; K. Hacene; πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 687 KB

An enzyme-linked immunosorbent assay using monoclonal and polyclonal antibodies against recombinant pS2 was devised. It was used to measure pS2 concentration in the cytosol of 339 breast cancers, 15 fibroadenomas, 16 cases of benign breast disease, and 6 normal breast tissues. The mean value of pS2

Polymorphisms in genes of the steroid re
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy
✍ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 183 KB πŸ‘ 1 views

## Abstract Menopausal hormone therapy (HT) is associated with increased breast cancer risk among postmenopausal women. Nuclear receptors are involved in steroid hormone‐ and xenobiotic‐mediated signal transduction playing a crucial role in regulating gene expression. Therefore, variations within t

Prognostic factors of early distant recu
Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy : Results of a retrospective analysis
✍ Marc Debled; GaΓ«tan MacGrogan; VΓ©ronique Brouste; Simone Mathoulin-Pelissier; Mi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Current adjuvant hormone therapy in postmenopausal women with breast cancer is debatable between upfront aromatase inhibitors (AIs) and sequential treatment with tamoxifen. A major concern is the higher rate of early recurrences observed with sequential treatment. The aut

High expression of 90K (Mac-2 BP) is ass
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies
✍ Nicola Tinari; Rossano Lattanzio; Patrizia Querzoli; Clara Natoli; Antonino Gras πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 234 KB

## Abstract 90K (Mac‐2 BP) expression was evaluated by immunohistochemistry in paraffin‐embedded tissue from a consecutive series of lymph‐node negative breast cancer patients who did not receive adjuvant systemic treatment. An independent series of patients served as validation set. The associatio